Evidence map›Paper›PMID 41070201›Full record

ArticleInterventional radiology (Higashimatsuyama-shi (Japan)2025

Modified Sharp Recanalization for Inferior Vena Cava Occlusion in Patient with Budd-Chiari Syndrome.

Shingo Koyama, Yuya Koike, Asako Nogami, Toru Nagata, Shinjiro Aso, Daichi Kojima, Masato Yoneda, Daisuke Utsunomiya

Abstract readCase Reports
In one paragraph

Article in Interventional radiology (Higashimatsuyama-shi (Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shingo KoyamaDepartment of Diagnostic Radiology, Yokohama City University Graduate School of Medicine, Japan.
Yuya KoikeDepartment of Radiology, Nihon University School of Medicine, Japan.
Asako NogamiDepartment of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Japan.
Toru NagataDepartment of Diagnostic Radiology, Yokohama City University Graduate School of Medicine, Japan.
Shinjiro AsoDepartment of Diagnostic Radiology, Yokohama City University Graduate School of Medicine, Japan.
Daichi KojimaDepartment of Diagnostic Radiology, Yokohama City University Graduate School of Medicine, Japan.
Masato YonedaDepartment of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Japan.
Daisuke UtsunomiyaDepartment of Diagnostic Radiology, Yokohama City University Graduate School of Medicine, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of Budd-Chiari syndrome successfully treated with endovascular recanalization of an inferior vena cava occlusion using a modified sharp recanalization technique. A 45-year-old man presented with hepatic dysfunction, and contrast-enhanced computed tomography revealed a 1.5 cm chronic inferior vena cava occlusion. Standard sharp recanalization using the conventional end of a guidewire failed to cross the lesion. Therefore, we reshaped the end of a 0.035-inch guidewire into a sharper form, enabling successful penetration without the use of specialized devices. This modified technique, adapted from peripheral artery interventions, may offer a safer and more cost-effective option for treating fibrotic venous occlusions. Stepwise balloon dilation was subsequently performed to minimize complications. This report highlights the potential utility of a reshaped guidewire end as a practical alternative when the conventional technique fails.

Indexed as

Budd-Chiari syndromesharp recanalizationtriple balloon angioplasty

Identifiers

PMID41070201
PMCPMC12504021

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.